Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Bought by State of Tennessee Department of Treasury

State of Tennessee Department of Treasury lifted its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 7.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 180,175 shares of the company's stock after purchasing an additional 12,755 shares during the quarter. State of Tennessee Department of Treasury owned 0.09% of Cellebrite DI worth $3,969,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of CLBT. NewEdge Advisors LLC lifted its position in Cellebrite DI by 600.7% in the fourth quarter. NewEdge Advisors LLC now owns 3,910 shares of the company's stock worth $86,000 after buying an additional 3,352 shares during the last quarter. R Squared Ltd bought a new stake in shares of Cellebrite DI in the fourth quarter valued at about $100,000. Polen Capital Management LLC bought a new stake in shares of Cellebrite DI in the fourth quarter valued at about $222,000. Victory Capital Management Inc. bought a new stake in shares of Cellebrite DI in the fourth quarter valued at about $234,000. Finally, HighTower Advisors LLC purchased a new position in Cellebrite DI in the fourth quarter valued at about $274,000. 45.88% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Lake Street Capital boosted their price target on Cellebrite DI from $17.00 to $26.00 and gave the stock a "buy" rating in a research note on Friday, February 14th. Needham & Company LLC restated a "buy" rating and set a $28.00 price target on shares of Cellebrite DI in a research note on Wednesday, April 2nd. Finally, JPMorgan Chase & Co. boosted their price target on Cellebrite DI from $24.00 to $28.00 and gave the stock an "overweight" rating in a research note on Tuesday, February 11th. Seven investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $23.43.

Cellebrite DI Stock Up 0.7 %

Shares of NASDAQ:CLBT traded up $0.14 during midday trading on Monday, reaching $19.78. The company's stock had a trading volume of 608,985 shares, compared to its average volume of 1,412,070. The firm has a market capitalization of $4.74 billion, a PE ratio of -14.23, a P/E/G ratio of 4.27 and a beta of 1.44. Cellebrite DI Ltd. has a twelve month low of $10.25 and a twelve month high of $26.30. The stock has a fifty day moving average of $18.73 and a 200 day moving average of $20.15.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.10 by ($0.03). Cellebrite DI had a positive return on equity of 58.70% and a negative net margin of 70.54%. Sell-side analysts anticipate that Cellebrite DI Ltd. will post 0.3 earnings per share for the current fiscal year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.